ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 12 filers reported holding ACASTI PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $115 | -8.0% | 250 | 0.0% | 0.00% | – |
| Q4 2022 | $125 | -87.5% | 250 | -87.5% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 2,000 | -60.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTACT INVESTMENT MANAGEMENT INC. | 48,990 | $81,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 40,000 | $52,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 154,427 | $199,000 | 0.00% |
| BREWIN DOLPHIN LTD | 30 | $39 | 0.00% |
| Renaissance Technologies | 61,195 | $79,000 | 0.00% |
| ROYAL BANK OF CANADA | 4,075 | $5,000 | 0.00% |